Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,152 | 56 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $290.04 | 11 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $163.10 | 10 | $0 (2023) |
| Genentech USA, Inc. | $125.85 | 4 | $0 (2023) |
| Optinose US, Inc. | $109.85 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $98.55 | 6 | $0 (2023) |
| GENZYME CORPORATION | $94.92 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $91.48 | 5 | $0 (2023) |
| CONMED Corporation | $42.60 | 1 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $33.34 | 2 | $0 (2020) |
| Stryker Corporation | $32.04 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $192.94 | 9 | GENZYME CORPORATION ($47.07) |
| 2022 | $56.33 | 3 | GlaxoSmithKline, LLC. ($21.20) |
| 2021 | $104.11 | 4 | CONMED Corporation ($42.60) |
| 2020 | $123.82 | 7 | OptiNose US, Inc. ($38.67) |
| 2019 | $194.86 | 13 | Novartis Pharmaceuticals Corporation ($50.02) |
| 2018 | $201.23 | 10 | Genentech USA, Inc. ($91.56) |
| 2017 | $278.61 | 10 | Intuitive Surgical, Inc. ($278.61) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $15.45 | General |
| 08/15/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Immunology | ||||||
| 07/18/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/05/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Immunology | ||||||
| 05/02/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Immunology | ||||||
| 03/25/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Respiratory | ||||||
| 02/16/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/02/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: RESPIRATORY | ||||||
| 01/12/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/16/2022 | Stryker Corporation | XPRESS ENT DILATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: ENTELLUS | ||||||
| 09/27/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Respiratory | ||||||
| 04/12/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: RESPIRATORY | ||||||
| 10/20/2021 | CONMED Corporation | AIRSEAL (Device) | Food and Beverage | In-kind items and services | $42.60 | General |
| Category: GENERAL SURGERY | ||||||
| 09/20/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/08/2021 | GENZYME CORPORATION | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 03/18/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/15/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/02/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/16/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/10/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/25/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Respiratory | ||||||
| 02/04/2020 | ALK-Abello, Inc | Odactra (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Allergy and Immunology | ||||||
| 09/17/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: SURGERY | ||||||
| 09/03/2019 | Kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: ALLERGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,417 | 2,009 | $425,665 | $137,891 |
| 2022 | 14 | 1,582 | 2,158 | $465,645 | $175,503 |
| 2021 | 16 | 1,483 | 2,772 | $474,184 | $175,610 |
| 2020 | 10 | 1,457 | 2,077 | $380,969 | $133,776 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 473 | 742 | $109,000 | $45,455 | 41.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 358 | 358 | $74,335 | $26,785 | 36.0% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 115 | 195 | $81,900 | $24,559 | 30.0% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 187 | 248 | $107,885 | $21,965 | 20.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 238 | 417 | $37,370 | $15,234 | 40.8% |
| 30901 | Simple control of nose bleed | Office | 2023 | 13 | 16 | $4,960 | $1,855 | 37.4% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 21 | 21 | $7,875 | $1,259 | 16.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $2,340 | $779.40 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 603 | 960 | $134,400 | $65,531 | 48.8% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 215 | 296 | $111,320 | $28,912 | 26.0% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 137 | 198 | $83,160 | $28,787 | 34.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 277 | 277 | $56,785 | $22,733 | 40.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 164 | 235 | $19,975 | $9,783 | 49.0% |
| 30520 | Reshaping of nasal cartilage | Facility | 2022 | 14 | 14 | $16,940 | $7,333 | 43.3% |
| 31255 | Removal of nasal sinus using an endoscope | Facility | 2022 | 12 | 12 | $13,035 | $2,856 | 21.9% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 72 | 75 | $7,600 | $2,468 | 32.5% |
| 30901 | Simple control of nose bleed | Office | 2022 | 15 | 16 | $5,270 | $1,957 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 15 | $3,075 | $1,514 | 49.2% |
| 70486 | Ct scan of face without contrast | Office | 2022 | 19 | 19 | $7,125 | $1,292 | 18.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 13 | $2,535 | $1,036 | 40.9% |
| 69200 | Removal of foreign body in ear canal | Office | 2022 | 11 | 11 | $2,640 | $699.16 | 26.5% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 17 | 17 | $1,785 | $602.68 | 33.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 672 | 1,168 | $186,880 | $73,782 | 39.5% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 123 | 174 | $69,600 | $25,750 | 37.0% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 179 | 259 | $51,800 | $24,603 | 47.5% |
About Dr. Mark Frattali, M.D
Dr. Mark Frattali, M.D is a Otolaryngology healthcare provider based in Scranton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649270174.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Frattali, M.D has received a total of $1,152 in payments from pharmaceutical and medical device companies, with $192.94 received in 2023. These payments were reported across 56 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,152).
As a Medicare-enrolled provider, Frattali has provided services to 5,939 Medicare beneficiaries, totaling 9,016 services with total Medicare billing of $622,781. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Location Scranton, PA
- Active Since 07/27/2005
- Last Updated 12/30/2021
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1649270174
Products in Payments
- Da Vinci Surgical System (Device) $290.04
- FASENRA (Drug) $127.55
- Xolair (Biological) $125.85
- Xhance (Drug) $109.85
- DUPIXENT (Biological) $80.41
- TRELEGY ELLIPTA (Drug) $60.96
- AIRSEAL (Device) $42.60
- XOLAIR (Drug) $41.46
- Odactra (Drug) $27.83
- BREO (Drug) $26.44
- CIPRODEX (Drug) $25.02
- LIBTAYO (Biological) $25.00
- XOLAIR (Biological) $25.00
- DUPIXENT (Drug) $22.85
- FASENRA (Biological) $21.13
- XPRESS ENT DILATION SYSTEM (Device) $20.71
- TEZSPIRE (Biological) $14.42
- RELIEVA Spin Balloon Sinuplasty System (Device) $13.60
- AUVI-Q (Drug) $13.25
- SPIROX - LATERA (Device) $11.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Scranton
John Sirotnak, Md, MD
Otolaryngology — Payments: $2,325
Dr. Keith Pritchyk, M.d, M.D
Otolaryngology — Payments: $907.07
Dr. Anthony Brutico, M.d, M.D
Otolaryngology — Payments: $563.13
Katherine Larrabee, Md, MD
Otolaryngology — Payments: $81.37
Dr. William Wood, M.d, M.D
Otolaryngology